HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eugene Maraskovsky Selected Research

influenza matrix peptide (58-66)

3/2005Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination.
7/2003Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eugene Maraskovsky Research Topics

Disease

25Neoplasms (Cancer)
10/2020 - 08/2002
12Melanoma (Melanoma, Malignant)
10/2020 - 07/2003
8Human Influenza (Influenza)
06/2014 - 07/2003
7Testicular Neoplasms (Testicular Cancer)
07/2010 - 08/2002
6Inflammation (Inflammations)
06/2014 - 01/2002
4Infections
09/2003 - 01/2002
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019 - 01/2016
3Communicable Diseases (Infectious Diseases)
07/2013 - 07/2009
2Prostatic Neoplasms (Prostate Cancer)
10/2020 - 03/2015
2Hemophilia A (Haemophilia)
01/2020 - 01/2019
2Febrile Seizures (Febrile Seizure)
06/2014 - 06/2014
2Virus Diseases (Viral Diseases)
03/2008 - 02/2004
1Adenocarcinoma
10/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2020
1Hemorrhage
01/2020
1Uveitis
01/2016
1Body Weight (Weight, Body)
06/2014
1Arthritis (Polyarthritis)
06/2014
1Vaccine-Preventable Diseases
04/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2011
1Hypersensitivity (Allergy)
07/2004
1Breast Neoplasms (Breast Cancer)
07/2004
1Colorectal Neoplasms (Colorectal Cancer)
07/2004
1Carcinogenesis
07/2004
1Squamous Cell Carcinoma of Head and Neck
07/2004
1Head and Neck Neoplasms (Head and Neck Cancer)
07/2004
1Experimental Melanoma
04/2004
1Renal Cell Carcinoma (Grawitz Tumor)
08/2002

Drug/Important Bio-Agent (IBA)

18VaccinesIBA
10/2020 - 04/2004
15AntigensIBA
04/2015 - 08/2002
8ISCOMATRIXIBA
01/2020 - 04/2004
7Cancer VaccinesIBA
10/2020 - 04/2008
7Proteins (Proteins, Gene)FDA Link
10/2020 - 04/2004
6CytokinesIBA
01/2019 - 04/2002
5Neoplasm Antigens (Tumor Antigens)IBA
10/2020 - 04/2004
5EpitopesIBA
01/2012 - 07/2004
5MART-1 AntigenIBA
01/2012 - 07/2003
5Peptides (Polypeptides)IBA
09/2006 - 07/2003
3Influenza Vaccines (Influenza Vaccine)FDA Link
06/2014 - 12/2012
3CD40 Ligand (CD40L)IBA
09/2006 - 01/2002
2Poly I-CIBA
10/2020 - 03/2015
2InterferonsIBA
10/2020 - 01/2019
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020 - 09/2006
2Factor VIII (Coagulation Factor VIII)IBA
01/2020 - 01/2019
2Toll-Like Receptor AgonistsIBA
03/2015 - 02/2011
2Combined VaccinesIBA
03/2015 - 02/2011
2ChemokinesIBA
06/2014 - 07/2003
2Immunoglobulin G (IgG)IBA
06/2014 - 07/2004
2ISCOMsIBA
07/2011 - 02/2011
2NucleotidesIBA
03/2008 - 07/2003
2Interferon Type IIBA
03/2008 - 02/2004
2flt3 ligand protein (flt3 ligand)IBA
09/2006 - 09/2004
2influenza matrix peptide (58-66)IBA
03/2005 - 07/2003
2Monophenol Monooxygenase (Tyrosinase)IBA
03/2005 - 09/2004
1prostatic acid phosphataseIBA
10/2020
1RNA (Ribonucleic Acid)IBA
01/2019
1Interleukin-3 (Interleukin 3)IBA
01/2019
1Biological ProductsIBA
01/2016
1AutoantibodiesIBA
01/2016
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2015
1Intravenous Immunoglobulins (IVIG)FDA Link
06/2014
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
06/2014
1Therapeutic UsesIBA
06/2014
1CollagenIBA
06/2014
1HLA-B18 AntigenIBA
01/2012
1Cell Surface ReceptorsIBA
01/2012
1Differentiation AntigensIBA
07/2010
1Histocompatibility Antigens Class IIBA
02/2010
1Antigen-Antibody Complex (Immune Complex)IBA
02/2009
1GTP-Binding Proteins (G-Protein)IBA
03/2008
1Hepatitis B Core AntigensIBA
09/2006
1Protein Subunit VaccinesIBA
03/2005
1Imiquimod (Aldara)FDA LinkGeneric
09/2004
1LigandsIBA
09/2004
1Complementary DNA (cDNA)IBA
07/2004
1AntibodiesIBA
07/2004
1Amino AcidsFDA Link
04/2004
1HLA-A2 Antigen (HLA A2 Antigen)IBA
04/2004
1Adenosine (Adenocard)FDA LinkGeneric
02/2004
1Purinergic P1 Receptors (Adenosine Receptor)IBA
02/2004
1Interleukin-12 (IL 12)IBA
07/2003
1Adenosine Triphosphate (ATP)IBA
07/2003
1DNA (Deoxyribonucleic Acid)IBA
08/2002
1DecitabineFDA Link
08/2002

Therapy/Procedure

8Immunotherapy
03/2015 - 03/2005
6Therapeutics
01/2019 - 07/2003
1Investigational Therapies (Experimental Therapy)
07/2004